![Eddie Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eddie Sullivan
Fondateur chez
SAB BIOTHERAPEUTICS, INC.
Fortune : 2 M $ au 31/08/2026
Profil
Eddie J.
Sullivan is the founder of SAB Sciences, Inc., founded in 2014, serving as President, Chief Executive Officer & Director.
Dr. Sullivan is the founder of SAB Biotherapeutics, Inc., founded in 2014, serving as President & Director.
Dr. Sullivan was the founder of South Dakota Biotech Association, founded in 2005, serving as President from 2005 to 2015.
Dr. Sullivan currently works as Director at Biotechnology Innovation Organization.
Former jobs include President & Chief Executive Officer at Hematech, Inc. from 2009 to 2012 and Chairman at The National Science Foundation.
Education includes graduate degrees from Warren National University LLC, Brigham Young University, and Utah State University, and an undergraduate degree from the University of Arizona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 523 230 ( 0,68 % ) | 2 M $ | 31/08/2026 |
Postes actifs de Eddie Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Fondateur | 01/07/2014 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Fondateur | 01/01/2014 |
Anciens postes connus de Eddie Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
South Dakota Biotech Association | Fondateur | 01/07/2015 |
Hematech, Inc.
 Hematech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | 01/12/2012 |
The National Science Foundation
 The National Science Foundation Miscellaneous Commercial ServicesCommercial Services Supports fundamental science and engineering researches | Président | - |
Formation de Eddie Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Warren National University LLC
 Warren National University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah State University
 Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hematech, Inc.
Hematech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The National Science Foundation
The National Science Foundation Miscellaneous Commercial ServicesCommercial Services Supports fundamental science and engineering researches | Commercial Services |
South Dakota Biotech Association | |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
